Stock Information
Ocular Therapeutix Inc (OCUL)
Ticker Symbol: OCUL
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,808.77 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.4385
Revenue (TTM): $0.23 M
Dividend Yield: N/A%
ROE: -71.66%
Latest News
-
Ocular Therapeutix reports inducement grants under Nasdaq listing rule 5635(c)(4)
Fri, May 8, 2026 4:21 PM
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fri, May 8, 2026 4:05 PM
-
Ocular: SOL-1 Success Is Real, But Adoption Risks Keep Me At Hold
Thu, May 7, 2026 8:00 AM
-
RBC Capital Reiterates Outperform on Ocular Therapeutix, Maintains $30 Price Target
Wed, May 6, 2026 11:49 AM
-
Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 2:41 PM
-
Transcript : Ocular Therapeutix, Inc., Q1 2026 Earnings Call, May 05, 2026
Tue, May 5, 2026 2:35 PM
-
Ocular Therapeutix Inc (NASDAQ:OCUL) Misses on Revenue and EPS in Q1 2026, Stock Dips
Tue, May 5, 2026 12:29 PM
-
Ocular Therapeutix: Q1 Earnings Snapshot
Tue, May 5, 2026 7:32 AM
-
Earnings Scheduled For May 5, 2026
Tue, May 5, 2026 7:12 AM
-
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
Tue, May 5, 2026 7:02 AM
Key Financials
Financial data not available
